Search All Applications in Cannabis: Processing
Application US20200061004
Published 2020-02-27
Compositions And Methods For Delivering Cannabidiol And Ketone Bodies
Disclosed herein are “ketonnabidiol” or “ketannabidiol” compositions including a combination of: (1) cannabidiol (CBD) and/or cannabidiolic acid (CBDA); (2) a ketone body component such as beta-hydroxybutyrate (BHB) and/or acetoacetate; and (3) a dietetically or pharmaceutically acceptable carrier. Also disclosed herein are methods of using such ketonnabidiol compositions for producing desired physiological effects, such as fat loss, in a mammal. The ketonnabidiol compositions beneficially enhance fat loss through ketosis while also reducing the duration and/or severity of unpleasant “keto flu” symptoms typically associated with ketosis.
Much More than Average Length Specification
View the Patent Matrix® Diagram to Explore the Claim Relationships
USPTO Full Text Publication >
- 1. A composition comprising:
a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; and a cannabidiol (CBD) component.
- 2. (canceled)
- 4. (canceled)
- 6. (canceled)
- 10. (canceled)
- 12. A composition comprising:
a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; and a cannabidiol (CBD) component, wherein the composition is in a dosage form that provides a unit dose of about 0.5 grams to about 50 grams of the ketone body component and a unit dose of about 3 mg to about 1 gram of the CBD component.
- 14. (canceled)
- 15. (canceled)
- 16. A method for administering ketone bodies and cannabidiol (CBD) to a mammal, comprising:
administering a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; and administering a CBD component.
- 18. (canceled)
